391 results on '"Qi, Miao"'
Search Results
2. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis
3. NUDT1 promotes the accumulation and longevity of CD103+ TRM cells in primary biliary cholangitis
4. Repair versus replacement for active endocarditis of the mitral valve: 9 years of experience
5. Is Malignancies Related Gastrointestinal Bleeding Safe for Cardiopulmonary Bypass Surgery? - A Case-control Study
6. <scp>IL</scp> ‐26 modulates T cell function in autoimmune hepatitis
7. Reversible Myocardial Calcification Following Acute Heart Failure and Kidney Injury Caused by Valsalva Sinus Rupture
8. Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the Literature
9. Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension
10. Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer
11. Non–open-heart surgery for intravascular leiomyomatosis extending from the inferior vena cava to the right heart chamber
12. Neurocognitive trajectories and their clinical implications in first-episode schizophrenia after one year of antipsychotic treatment
13. Outcomes of surgical treatment for active infective endocarditis under COVID‐19 pandemic
14. Mediating Role of Hope Between Social Support and Self-Management Among Chinese Liver Transplant Recipients: A Multi-Center Cross-Sectional Study
15. Giant coronary aneurysm of Behcet's disease with sudden syncope: a case report
16. Data from BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
17. Supplementary Figure from BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
18. circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
19. Supplementary Table S1 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
20. Supplementary Figure S3 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
21. Supplementary Figure S8 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
22. Supplementary Figure S7 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
23. Supplementary Figure S2 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
24. Supplementary Figure S9 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
25. Supplementary Materials and Methods from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
26. Supplementary Figure S6 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
27. Supplementary Figure S5 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
28. Supplementary Table S2 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
29. Supplementary Figure S4 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
30. Supplementary Figure S1 from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
31. Data from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
32. A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression
33. Differences in Cardiac Rupture and Hemopericardium Caused by Blunt Chest Injury, Acute Myocardial Infarct, Aortic Dissection and CPR
34. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases
35. Racial Disparities in Quantitative MRI for African American and White Men with Prostate Cancer
36. A general photo-induced wide-scope regioselective hydroboration of alkenes without using a photocatalyst or an external initiator
37. Visible-light-induced 1,2-diphenyldisulfane-catalyzed regioselective hydroboration of electron-deficient alkenes
38. Maize productivity response to combined tillage and mulching in coastal saline zones
39. Effect of Systematic Alanine Mutation and Peptide Stapling on the Antibacterial Activity of a Short Amphiphilic Peptide
40. A Numerical Study of Effects of Bypass Current on Physical Fields and Thermal Transfer in Hybrid Variable Polarity Plasma Arc
41. Research and Application of Energy Efficiency Optimization Algorithm for Spacecraft Simulation Platform
42. The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis
43. Implementation of Spacecraft Test Data Unidirectional Cross-Network Transmission System
44. Optimizing Phosphorus Application for Winter Wheat Production in the Coastal Saline Area
45. Construction of nursing quality evaluation index system for kidney transplant patients: a Delphi method
46. Pd‐Catalyzed Asymmetric Addition of Arylboronic Acids to Pyrazolinone Ketimines
47. No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial
48. Diatomite-based magnesium sulfate composites for thermochemical energy storage: Preparation and performance investigation
49. Surgical treatment for active infective endocarditis: progress and challenges
50. Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.